ArticleArthroplasty today2026
Contemporary Survivorship of Highly Porous Hemispherical Shells in Aseptic Acetabular Revision Total Hip Arthroplasty.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Contemporary performance of revision hemispherical shells in acetabular revision total hip arthroplasty (rTHA) remains limited. This study evaluated survivorship free from revision for aseptic acetabular loosening, all-cause revision, and all-cause reoperation, as well as dislocation rate and patient-reported outcomes (PROMs) following aseptic rTHA with modern, highly-porous, revision acetabular components. Methods: We identified 127 patients (mean age 66, mean body mass index 27, 57% female) who underwent aseptic rTHA with hemispherical shells from 2016 to 2022 with minimum 2-year potential follow-up. Paprosky defects type was I in 20%, II in 70%, and III in 10%. Cases using augments or cages were excluded. A posterolateral approach was used in 98% of patients, and 21% of patients underwent concomitant femoral revision. A mean of 3 (range, 0-5) screws were used. Liners included dual mobility (n = 94), elevated (n = 15), neutral (n = 12), constrained (n = 4), and offset (n = 2). Kaplan-Meier survivorship analysis assessed time-to-event outcomes. Results: At 2 years, survivorship free from revision for aseptic acetabular loosening was 97%, and free from all-cause revision was 94%. Revision indications included dislocation (n = 4), aseptic loosening (n = 2), periprosthetic joint infection (n = 1), and metallosis (n = 1). Dislocation occurred in 7 patients (6%). At 2 years, there was a median 21.4-point increase in the Hip Injury and Osteoarthritis Outcome Score for Joint Replacement ( Conclusions: Modern, highly-porous revision hemispherical shells with multiple screw fixation have excellent 2-year survivorship free from aseptic loosening (97%) but modest dislocation rate (6%). These results support the use of contemporary hemispherical shells but highlight the need for instability prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.